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ORIGINAL ARTICLE 
Polymerase chain reaction (PCR) compared with 
conventional identification in culture for detection of 
Bordetella pertussis in 7153 children 
Gabriela Schrnidt-Schlapfer7*, Johannes G. Liese’, Frank Porter’, Sylvia Stojanov’, 
MaxJust’ and Bernd H. Belohradsky2 
‘University Children’s Hospital, Basel, Switzerland, and 2University Children’s Hospital, Munich, 
Germany 
Objective: To compare the polymerase chain reaction (PCR) results with conventional culture results for the diagnosis 
of Bordetella pertussis infections. 
Methods: PCR and culture were performed in the course of a large vaccine efficacy trial in Germany on specimens 
taken from 7153 children 52 years of age with cough illness lasting >6 days, and laboratory results were compared with 
clinical data also obtained from the patients. Calcium alginate nasopharyngeal swabs were taken for culture and clinical 
data were obtained from patients. Swabs were inoculated on charcoal horse blood agar plates containing cephalexin, 
and then discarded. The agar plateswere preincubated for 2 days at the physician’s office and then shipped to the culture 
laboratory at the University Children’s Hospital in Munich, Germany, for diagnosis of €3. pertussis and B. parapertussis 
infections. In this laboratory, Dacron swabs for PCR were taken from each culture by a wide sweep over the culture. 
Swabs for PCR were stored in NaCl and sent weekly to  the PCR laboratory at the University Children‘s Hospital in Basel, 
Switzerland, for PCR diagnosis of B. pertussis infections. 
Results: B. pertussis was identified by culture in  3% (213/7153) and by PCR in 7.6% (546/7153) of the specimens. 
Therefore, PCR increased the identification rate of subjects with B. pertussis infection 2.6-fold. Clinical characteristics 
were considered according to  the type of laboratory findings: group 1 consisted of 209 culture-positive and PCR-positive 
subjects, and group 2 of 337 culture-negative but PCR-positive subjects. Group 2 subjects were significantly more likely 
to have mild or atypical clinical symptoms of whooping cough than were group 1 subjects. By analyzing the PCR results 
of group 2 subjects semiquantitatively, it could be shown that the degree of PCR positivity correlated with the severity 
of the clinical symptoms of whooping cough in the patient. 
Conclusions: PCR identified many pertussis cases with mild or atypical clinical symptoms that were not identified by 
culture. Semiquantification of PCR products revealed that the less positive the PCR result, the higher was the failure rate 
in diagnosing pertussis by culture, and, in addition, the less typical were the clinical symptoms in the patient. 
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INTRODUCTION 
The laboratory diagnosis of Bordetella pertussis infection 
is not always straightforward. Culture of the organism 
is specific but lacks sensitivity, whereas demonstration 
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of the presence of B. pertussis bacteria by direct 
fluorescent antibody staining, in specimens from the 
nasopharynx, is less specific but often more sensitive 
[1,2]. The sensitivity of the culture method is inversely 
related to the duration of illness, and is decreased in 
previously vaccinated persons as well as in patients 
treated with antibiotics [1-51. B. pertussis infections can 
also be diagnosed by serologic tests. These, however, 
require the demonstration of a significant rise in 
antibody titer between an acute- and a convalescent- 
phase serum sample, which results in a considerable 
delay in diagnosis [6-81. 
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Recently, several investigators, including members 
of our group, have reported the use of PCR to identify 
B. partusris genetic material in nasopharyngeal speci- 
mens from patients with respiratory illnesses 19-21], 
Results varied among studies because of differing 
methods of sampling, preparation of samples for PCK,  
selection of primers, and detection of PCR products. 
Nevertheless, there has been suggestive evidence that 
PCK is more sensitive than culture and, in particular, 
niay detect cases with mild or atypical clinical synip- 
toms of whooping cough that cannot be detected by 
culture. Because of the potential indicated by these 
results, we included P C R  in this study and compared 
it with culture as well as with the clinical syniptoms of 
patients. 
MATERIALS AND METHODS 
Collection and inoculation of specimens 
In a large German study to evaluate the efficacy of a 
new acellular pertussis vaccine, cases of pertussis were 
detected in 63 pediatric practices by culturing naso- 
pharyngeal swab specimens from all children 5 2  years 
of age with cough illness lasting >6 days. A calcium 
alginate nasopharyngeal swab was taken from each 
patient and inoculated on a charcoal horse blood agar 
plate containing 40 pg/niL cephalexin as described by 
Liese et a1 [22]. Culture plates were incubated at 36°C 
at the physician’s office for 2 days and then mailed to 
the culture laboratory for cultural diagnosis. 
PCK was added to the culture method to diagnose 
B. pertussis infections, after the study had already 
started. For this reason, P C R  had to be performed from 
swabs taken from the culture plates, and not directly 
from the patients. From each culture plate with visible 
bacterial growth, or at the latest after 7’ days of incub- 
ation, a Dacron swab for PCK was taken. To prevent 
contamination, swabs for P C R  were taken in a separate, 
non-bacteriologic laboratory under senii-sterile condi- 
tions. As a negative control, and to monitor possible 
carryover contamination, a further 1248 Dacron swabs 
for P C R  were taken from sterile culture plates. These 
were incubated for 7 days and opened daily, together 
with the inoculated culture plates. Inoculated swabs for 
PCK were stored in 0.4 InL NaCl solution (0.9%) at 
4°C and sent weekly to the PCK laboratory. 
Culture and PCR 
Culture diagnosis was performed for B. pertirrsis and 
B. parapertussis as recommended by Hoppe et a1 [23]. 
In short, colony morphology, oxidase reaction and 
agglutination with specific antisera (Wellcome Diag- 
nostica, Germany) were tested. Positive results are 
described as ‘culture-positive’. 
P C K  was performed as described previously 
[19,21]. Briefly, samples were lysed and digested with 
proteinase K, DNA was extracted with phenol/ 
chloroform, and purified DNA was redissolved in 
sterile water. Amplifications were carried out using the 
primers PTpl and PTp2 [17], yielding a 191 -bp DNA 
fragment of the pertussis toxin operon. Carryover 
prevention was provided by the uw of uracil-I>NA 
glycosylase (UDG; Gibco BRL, USA). P C R  products 
were analyzed by dot blotting on nylon membrane?, 
followed by hybridization with a 5’ digoxigenin- 
labeled specific oligonucleotide probe. Detection of 
dotted P C R  products was carried out by chenli- 
luminescence as recommended by the supplier 
(Boehringer, Germany). The detected P C R  products 
were visually graded as 1+, 2+ or 3+, respectively, 
representing about 1-10, 11-50 and >50 B. pertcissir 
organisms, as described previously [21]. Specificity 
control of the primers was carried out as described 
previously [19,21]. Positive results are described as 
‘PCR-positive’. 
Clinical information obtained by questionnaire 
From all patients included in the study, the following 
information was obtained and documented in a 
questionnaire: patient’s name and date of birth, date 
of swab collection, results of culture and PCR,  total 
duration of the cough, total duration of paroxysms, 
occurrence of post-tussive vomiting and whooping, 
antibiotic treatment, vaccination status, and, finally, 
the physician’s judgment as to whether pertussis was 
definite, probable or unlikely. When culture and/or 
P C R  was positive for B. perttrsrir, the physician made 
weekly follow-up phone calls to the patient until the 
cough stopped, or at most for 21 days. 
Statistics 
The Pearson chi-squared test was used to compare 
percentages of clinical symptonis related to different 
groups in Tables 2 and 3. 
RESULTS 
General 
The overall laboratory results are presented in Table 1. 
B. pertussis grew in 213 (3%) and B. parupertussis in 49 
(0.7%) of the 7153 specinlens from children 5 2  years 
of age with cough illness lasting >6 days. Of  the 6891 
culture-negative specimens, 337 (5%) were PCK- 
positive for B. pertussis. Therefore, I’CR increased 
the identification rate of subjects with B. yertusrir 
infections 2.6-fold. Of  the 21 3 culture-positive speci- 
mens, 209 (98%) were also P C R  positive. When the 
four PCR-negative but culture-positive specimens 
4 6 4  Cl in ica l  M i c r o b i o l o g y  and In fec t ion ,  Vo lume 3 Number  4,  August  1 9 9 7  
Table 1 Culture and PCR findings in 7153 subjects 
5 2  years with cough illness >6 days duration 
PCR results 
Category 
Culture No. No. 
result negative positive 
Bordetella pertussis not isolated 6891 6603 337 
Borderella pertussis isolated 213 4 209 
Bordetella parapertclssis nolated 49 23 26 
Total 7153 6630 572 
were re-examined by P C R  at a 1 : 10 dilution, they were 
also PCK positive. Of  the 1248 negative controls (un- 
inoculated plates), 16 (1.3%) were P C R  positive. All 
test series in which a negative control was found to be 
PCR positive were excluded from further evaluations. 
Clinical characteristics 
Clinical information reported by questionnaire was 
related to the groups defined according to the labor- 
atory results, and is presented in Table 2. Group 1 
subjects were culture positive and P C R  positive, and 
group 2 subjects were culture negative but P C R  
positive. Ninety-six per cent of group 1 subjects were 
judged by the physicians to have probable or definite 
pertussis, whereas only 72% of group 2 subjects had 
such a diagnosis. Accordingly, significantly more 
(P<O.OOl) subjects from group 1 than from group 2 
had a long cough duration of 2 2 1  days (91% versus 
65%), paroxysms lasting 2 7  days (82% versus 34%), 
whooping inspiration (75% versus 31%), and post- 
tussive vomiting (68% versus 30%). The difference 
between group 1 and group 2 was highest for 
paroxysms (48%) more patients in group 1 than in group 
2 had paroxysms), followed by the differences for 
whooping inspiration (44%), post-tussive vomiting 
(38%) and cough duration 2 2 1  days (26%). O n  the 
other hand, group 2 subjects had received pertussis 
vaccine significantly more often (P<O.OOl) than group 
1 subjects (54% versus 23%). Surprisingly, there is no 
significant difference in P C R  positivity between group 
1 and group 2, whether or not patients were treated 
with antibiotics before sampling (P= 0.695). 
Analysis of group 2 by PCR grade 
Clinical characteristics of the 337 subjects who had 
PCK-positive and culture-negative results (group 2) 
were analyzed by semiquantitative interpretation of 
P C R  positivity. This analysis is presented in Table 3. 
Subjects with high P C R  positivity (3+ values) had a 
probable or definite clinical diagnosis of pertussis (85%) 
significantly more often (P<0.001) than those with low 
P C R  positivity (1 + values; 60%). Accordingly, the 
percentage of cases with a long cough duration of 2 2 1  
days, paroxysms, whooping inspiration and post-tussive 
vomiting was significantly higher (P<0.001) among 
subjects with 3+ values than among those with 1+ 
values. The difference between subjects with 3+ values 
and those with 1+ values was highest for paroxysms 
(66% more subjects with 3+ values had paroxysms than 
subjects with 1+ values), followed by the differences 
for whooping inspiration (51%), post-tussive vomiting 
(39%) and cough duration 221  days (36%). O n  the 
Table 2 Clinical characteristics of 546 subjects, of whom 209 were culture positive and PCR positive (group 1) and 337 
were culture negative and PCR positive (group 2) 
Clinical characteristics 
PCK positive 
Group 1 Group 2 
culture positive culture negative 
n=209 (%) n=337 (%) 
- Statistical analyses (Qa 
P 
Clinical diagnosis of probable or definite pertussis 201 (96) 242 (72) <0.001 
Final duration of cough: 0-6 days 1 (0.5) 1 (0.3) <0.001 
Final duration of cough: 7-14 days 10 (5) 50 (15) < 0.00 1 
Final duration of cough: 15-20 days 7 (3) 56 (17) <0.001 
Final duration of cough: 21-27 days 42 (20) 68 (20) <0.001 
Final duration of cough: 2 2 8  days 148 (71) 151 (45) <0.001 
Paroxyqms: 0 days 21 (10) 161 (48) <0.001 
Paroxysms: 1-6 days 16 (8) 48 (14) <0.001 
Paroxysms: 7-14 days 62 (30) 51 (15) <0.001 
Paroxysms: 15-20 days 36 (17) 18 (5) <0.001 
Paroxysms: 2 2 1  days 73 (35)  48 (14) <0.001 
Whooping inspiration 157 (75) 104 (31) <0.001 
Post-tussive vomiting 141 (68) 102 (30) <0.001 
Vaccination status 2 1 dose of pertussis vaccine 49 (23) 181 (54) <0.001 
Antibiotic therapy before sampling 12 (6) 17 ( 5 )  0.695 
"P: group 1 versus group 2. 
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Table 3 Clinical characteristics o f  337 subjects whose PCK saniples were positive and  whose cultures were negative 
(group 2) analyzed by the degree o f  positivity of the PCK” 
Clinical characteristics 
~~ ~ 
P C R  positive Statistical analyses (P)” 
1 +  2+ 3+ 
positive powive pobitive 
rr=114 (I%) ,1=148 (5%) n=75 (%) P 
Clinical diagnosis of pi-obable or definite pertussis 
Final duration o f  cough: 7-14 days 
Final duration of cough: 15-20 days 
Find duration ofcough: 2 2 1  days 
Paro.ysnis: 0-6 days 
Paroxysms: 7-1 4 days 
ParoxyTnis: 15-20 days 
Paroxysms: 2 2 1 days 
Whooping inspiration 
Post-tussive vomiting 
Vaccination status 2 1 dose of pertussis vaccine 
Antibiotic therapy before sampling 
lluration of cough: 0-6 days 
68 (61)) 
22 (19) 
27 (24) 
59 (52) 
9.5 (84) 
7 (6) 
0 (0) 
6 (5) 
21 (18) 
4 (4) 
0 (0) 
15 (13) 
41 (36) 
11 0 (74) 
24 (16) 
26 (18) 
97 (65) 
26 (18) 
16 (11) 
41 (28) 
94 (64) 
6 (4) 
38 (26) 
94 (64) 
8 (5) 
1 (0.7) 
64 (85) 
4 (i) 
3 (4) 
66 (88) 
17 (23) 
18 (24) 
12 (16) 
26 (35) 
48 (64) 
43 (57) 
21 (28) 
5 (7) 
0 (0) 
~~ 
.’The PCR-amplified products detected were viwally rated as 1 +, 2+ or 3+, which represent 1-10, 11-50 and 2 5 0  Borderella pertussis 
bacteria, respectively. 
“P 1 + positive versus 3+  positive 
other hand, patients with short cough duration (7-14 
days) or no paroxysnis were significantly ( P < O . O O l )  
more likely to show a weak positive I’CR result (1+ 
values) than a strong positive PCK result (3+ values). 
Analysis of 49 subjects with culture-confirmed 
B. parapertussis infection 
Twenty-six of forty-nine (53%) cases with culture- 
confirmed B. purapevtussis infection were also P C R  
positive for B. pertussis. Clinical Characteristics of the 
49 subjects with culture-confirmed B. parapertussis 
infection and a positive or negative P C R  result for B. 
pertussis are summarized in Table 4. There are no 
significant differences between PCK positives and 
P C R  negatives in this group of patients with regard to 
the clinical symptoms. 
DISCUSSION 
In recent years, several laboratory and clinical studies 
have been performed using P C R  to diagnose B. 
pertussis infections, and this technique has been shown 
to be sensitive and specific €or the diagnosis of pertussis 
[9-211. However, in most of these reports, data on the 
patients’ illnesses and their clinical histories are limited. 
In a previous study by members of our group, evidence 
was found that in patients with n d d  o r  atypical clinical 
syniptoms of whooping cough and negative culture 
results, P C R  for B. pertussis was positive [19]. In 
another study, in which initial and follow-up clinical 
data from patients as well as culture results were 
available, we could confirni that patients with mild or 
atypical clinical symptoms of whooping cough and/or 
who had been vaccinated and/or treated with anti- 
biotics prior to sampling were often culture negative 
but P C R  positive [21]. In view of these results, we 
decided in this large efficacy study, for which culture 
diagnosis was performed and data about clinical symp- 
toms were collected, to include P C R  and to compare 
Table 4 Clinical characteristics of 26 Subjects with cultui-e- 
confirmed B. parapertussis infection who were PCR positive 
for B. pertussis 
B. pan2pertutssis isolated 
I’CR positive I’CR ncgative 
Clinical characteristics n=26 (?A) ~ = 2 3  (‘%) 
Clinical diagnosis of probable or 
Ihration of cough: 0-6 days 
Duration of cough: 7-14 days 
Duration of cough: 15-20 days 
Duration of cough: 21-27 days 
lhrat ion of cough: 228  days 
Paroxysms: 0 days 
Paroxysms: 1-6 days 
Paroxysms: 7-1 4 days 
Paroxysms: 15-20 days 
Paroxysms: 2 2 1  days 
Whooping inspiration 
Post-tussive vomiting 
Vaccination status 2 1 dose of 
pertussis vaccine 
Antibiotic therapy before sampling 
definite pertussis 22 (85) 
0 (0) 
4 (15) 
9 (35) 
9 (35) 
7 (27) 
5 (1% 
1 (4) 
2 (8) 
5 (19) 
7 (27) 
11 (42) 
13 (50) 
1 8 (h0) 
1 (4) 
19 (83)  
0 (0) 
2 (9) 
8 (35) 
5 (22) 
7 (30) 
I 1  (48) 
3 (13) 
0 (0) 
2 (9) 
5 (22) 
6 (26) 
6 (26) 
15 (65) 
1 (4) 
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P C R  results with culture results for the diagnosis of 
B. pertussis infections and to compare laboratory results 
with clinical syniptoms of patients. 
Subjects were studied if they were aged 5 2  years 
and had a cough illness lasting >6 days. The broadness 
of the inclusion criteria for this study accounts for the 
low overall culture isolation rate for B. pertussis (3%). 
The addition of P C R  to culture allowed us to increase 
the rate of pertussis diagnosis by a factor of 2.6-7.6%, 
from 213 to 546 patients (Table 1). Of  concern, how- 
ever, was the initial failure of P C R  to detect the 
infection in four subjects with culture-confirmed B. 
pertussis infection. A repeat of the PCR at a 1:lO 
dilution gave positive P C R  results in all four specimens. 
This observation had already been made in a previous 
study [21] and had been explained as a prozone-like 
effect: when there is a very large amount of pertussis 
DNA in the test tube, the primers cannot anneal to the 
corresponding pertussis sequences as rapidly as the two 
complementary DNA strands can reanneal during the 
annealing step of the P C R  procedure. This observation 
was made in <1% of PCR-positive cases, a negligible 
proportion in relation to the 2.6-fold enhancement of 
the detection rate by P C R  compared with culture. 
Repetition of PCR for all samples at 1 : l O  dilution is 
not to be recommended, as it would be much more 
laborious and expensive than the small improvement in 
sensitivity of PCK would warrant. 
To monitor possible contamination, 1248 negative 
control samples were included in the study and tested 
by PCR. Of  the negative control samples, 1.3% 
(16/1248) were P C R  positive. All series in which a 
negative control was P C R  positive were excluded froni 
further evaluations. Routinely every 2 weeks, and in 
addition when contamination occurred, extensive 
laboratory cleaning was performed, and cleanness was 
monitored by taking swabs for P C R  from all work 
stations. In the case of contamination, P C R  was also 
performed on all reagents used for P C R ,  until all 
negative controls were negative. Only when this was 
the case was P C R  work started again for diagnosis. 
Such extensive monitoring of possible contaminations 
(15% of all samples tested) is recommended for all 
diagnostic P C R  laboratories, to avoid false-positive 
results. 
Evaluation of clinical data in two groups which are 
defined by laboratory data (Table 2) revealed that B. 
pertussis infections were often identified by P C R  but 
not by culture (group 2) in subjects without a probable 
or definite clinical diagnosis of pertussis. Such patients 
often had mild or atypical clinical symptoms ofwhoop- 
ing cough, such as cough <21 days, no paroxysms, no 
whooping inspiration and/or no post-tussive vomiting. 
In addition, a gradation of cough duration and of 
paroxysm duration could be observed: group 2 subjects 
had a short duration of cough and paroxysms more 
often than group I subjects. These findings suggest that 
severity of illness and symptoms that are more clinically 
typical of pertussis are related to culture positivity, and 
that cases with mild or atypical clinical symptoms are 
often only detectable by P C R  and not by culture. 
Furthermore, subjects with prior vaccination, also 
often having mild or atypical clinical symptoms of 
whooping cough, were more often diagnosed only by 
PCR,  but not by culture. These observations confirm 
data from our earlier studies in which patients with 
mild or atypical clinical symptoms of whooping cough 
could often only be detected by PCR, but not by 
culture [19,21]. 
The grading of P C R  results of group 2 as 1 + , 2+ 
and 3+ (Table 3) showed that patients with 3+ values 
had more typical clinical symptoms of whooping cough 
significantly more often than patients with 1 + values. 
This was noted for the clinical diagnosis ofprobable or 
definite pertussis and for all clinical symptoms. These 
findings suggest that severity of illness and symptoms 
more clinically typical of pertussis are related to the 
concentration of organisms in nasopharyngeal speci- 
mens: the more bacteria that can be detected by P C K  
(grading 3+), the more severe and typical are the 
clinical symptoms of whooping cough in the patient. 
Of  concern is the apparent P C R  false-positive 
results for B. pertussir in 26 children from whom B. 
parupertussis was isolated (Tables 1 and 4). Such an 
observation may be explained by the occurrence of 
double infections with B. pertussis and B. pavupertussis, 
which is more common than is realized [24,25]. Our 
PCR method uses primers which amplify a fragment 
of the pertussis toxin operon which has been shown to 
be specific for B. pertussis [17,21], the only species to 
liberate this toxin. Primer specificity tests performed 
with clinical B. parapertussis strains gave no false-positive 
results [19,21]. Evaluation of clinical characteristics in 
subjects with culture-confirmed B. purupevtussis infec- 
tions and with positive P C R  results for B. pertussis 
revealed no significant differences with respect to the 
clinical symptoms from patients who had culture- 
confirmed B. parupertussis infections and negative P C R  
results (Table 4). Further evaluations with respect to 
such double infections are necessary and may be carried 
out with the recently described P C R  techniques, 
which identify both B. pertussis and B. parapertussis 
infections in a single P C R  reaction [11,14,16]. 
To summarize, the findings in this study show that 
P C R  is more sensitive than conventional identification 
in culture for the diagnosis of B. pertussis infections. In 
addition, the following correlation could be clearly 
demonstrated: the less positive the P C R  result, and 
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consequently the less B. pertussis bacteria in the clinical 
sample and in the patient, the more mild and/or 
atypical are the clinical symptoms in the patient. 
Therefore, P C R  is a potential method for diagnosing 
pertussis cases even with mild or atypical clinical 
syniptoms, which are also frequently seen in adults, in 
vaccinated patients and/or in antibiotic-treated patients 
[19,21]. Without PCR, such cases often go unrecog- 
nized, and therefore untreated, and consequently 
coniprise a source for the further spread of pertussis. 
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